Knudsen, C. S., Adelborg, K., Søndergaard, E. & Parkner, T. (2022).
Biotin interference in routine IDS-iSYS immunoassays for aldosterone, renin, insulin-like growth factor 1, growth hormone and bone alkaline phosphatase.
Scandinavian Journal of Clnical and Laboratory Investigation,
82(1), 6-11.
https://doi.org/10.1080/00365513.2021.2003854
Knudsen, J. S., Knudsen, S. S., Hulman, A., Witte, D. R., Gregg, E. W.
, Lauritzen, T., Pedersen, L., Sørensen, H. T. & Thomsen, R. W. (2022).
Changes in type 2 diabetes incidence and mortality associated with introduction of HbA1c as diagnostic option: A Danish 24-year population-based study.
The Lancet Regional Health - Europe,
14, Article 100291.
https://doi.org/10.1016/j.lanepe.2021.100291
Koning, M., Dumas, S. J., Avramut, M. C., Koning, R. I., Meta, E., Lievers, E., Wiersma, L. E., Borri, M., Liang, X., Xie, L., Liu, P., Chen, F.
, Lin, L., Luo, Y., Mulder, J., Spijker, H. S., Jaffredo, T., van den Berg, B. M.
, Carmeliet, P. ... Rabelink, T. J. (2022).
Vasculogenesis in kidney organoids upon transplantation.
npj Regenerative Medicine,
7(1), Article 40.
https://doi.org/10.1038/s41536-022-00237-4Kopchick, J. J., Basu, R., Berryman, D. E.
, Jorgensen, J. O. L., Johannsson, G. & Puri, V. (2022).
Covert actions of growth hormone: fibrosis, cardiovascular diseases and cancer.
Nature Reviews. Endocrinology,
18(9), 558-573.
https://doi.org/10.1038/s41574-022-00702-6Kostanjšek, R., Diderichsen, B., Recknagel, H., Gunde-Cimerman, N., Gostinčar, C., Fan, G., Kordiš, D., Trontelj, P., Jiang, H.
, Bolund, L. & Luo, Y. (2022).
Toward the massive genome of Proteus anguinus-illuminating longevity, regeneration, convergent evolution, and metabolic disorders.
Annals of the New York Academy of Sciences,
1507(1), 5-11.
https://doi.org/10.1111/nyas.14686Kristensen, N. M., Gribsholt, S. B., Andersen, A. L., Richelsen, B. & Bruun, J. M. (2022).
Obesity augments the disease burden in COVID-19: Updated data from an umbrella review.
Clinical Obesity,
12(3), Article e12508.
https://doi.org/10.1111/cob.12508
Kristensen, F. P. B., Christensen, D. H., Callaghan, B. C., Stidsen, J., Nielsen, J. S., Højlund, K.
, Staehelin-Jensen, T., Vestergaard, P.
, Jessen, N. & Thomsen, RW. (2022).
Type 2 diabetes phenotypes and polyneuropathy: a prevalence study in the DD2 Cohort.
Diabetologia,
65(Suppl. 1), Article 191.
Kristensen, F. P. B., Christensen, D. H., Callaghan, B. C.
, Svane, H. M. L., Stidsen, J., Nielsen, J. S., Højlund, K., Beck-Nielsen, H.
, Staehelin-Jensen, T., Andersen, H., Vestergaard, P., Jessen, N., Olsen, M. H., Hansen, T., Brøns, C., Vaag, A.
, Sørensen, H. T. & Thomsen, RW. (2022).
Type 2 diabetes phenotypes and polyneuropathy: A prevalence study in the DD2 cohort.
Pharmacoepidemiology and Drug Safety,
31(S2), 315-316. Article 690.
https://doi.org/10.1002/pds.5518
Langdahl, B., Hofbauer, L. C., Ferrari, S., Wang, Z., Fahrleitner-Pammer, A., Gielen, E., Lakatos, P., Czerwinski, E., Gimeno, E. J., Timoshanko, J., Oates, M. & Libanati, C. (2022).
Romosozumab efficacy and safety in European patients enrolled in the FRAME trial.
Osteoporosis International,
33(12), 2527-2536.
https://doi.org/10.1007/s00198-022-06544-2